Self-Reported Effects of Diet on Gastrointestinal Symptoms in Healthy Children.

Autor: Telborn L; From the Pediatrics, Department of Clinical Sciences, Lund University, Lund, Sweden.; the Department of Pediatric Surgery, Skane University Hospital, Lund, Sweden., Axelsson I; From the Pediatrics, Department of Clinical Sciences, Lund University, Lund, Sweden., Granéli C; From the Pediatrics, Department of Clinical Sciences, Lund University, Lund, Sweden.; the Department of Pediatric Surgery, Skane University Hospital, Lund, Sweden., Stenström P; From the Pediatrics, Department of Clinical Sciences, Lund University, Lund, Sweden.; the Department of Pediatric Surgery, Skane University Hospital, Lund, Sweden.

Publikováno v: Journal of pediatric gastroenterology and nutrition [J Pediatr Gastroenterol Nutr] 2023 Sep 01; Vol. 77 (3), pp. 433-438. Date of Electronic Publication: 2023 Jul 03.

A simeprevir-inducible molecular switch for the control of cell and gene therapies.

Autor: Chin SE; Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Schindler C; Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Vinall L; Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Dodd RB; Biologics Engineering, Oncology R&D, AstraZeneca, Cambridge, UK., Bamber L; Biologics Engineering, Oncology R&D, AstraZeneca, Cambridge, UK., Legg S; Biologics Engineering, Oncology R&D, AstraZeneca, Cambridge, UK., Sigurdardottir A; Biologics Engineering, Oncology R&D, AstraZeneca, Cambridge, UK., Rees DG; Biologics Engineering, Oncology R&D, AstraZeneca, Cambridge, UK., Malcolm TIM; Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Spratley SJ; Biologics Engineering, Oncology R&D, AstraZeneca, Cambridge, UK., Granéli C; BioPharmaceuticals R&D Cell Therapy Department, Research and Early Development, Cardiovascular, Renal, and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Sumner J; Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Tigue NJ; Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK. natalie.tigue@astrazeneca.com.

Publikováno v: Nature communications [Nat Commun] 2023 Nov 27; Vol. 14 (1), pp. 7753. Date of Electronic Publication: 2023 Nov 27.

A Computer Program for Assessing Histoanatomical Morphometrics in Ultra-High-Frequency Ultrasound Images of the Bowel Wall in Children: Development and Inter-Observer Variability.

Autor: Erlöv T; Department of Biomedical Engineering, Faculty of Engineering, Lund University, 22363 Lund, Sweden., Hawez T; Pediatrics, Department of Clinical Sciences, Faculty of Medicine, Lund University, 22185 Lund, Sweden., Granéli C; Pediatrics, Department of Clinical Sciences, Faculty of Medicine, Lund University, 22185 Lund, Sweden.; Department of Pediatric Surgery, Skåne University Hospital Lund, 22185 Lund, Sweden., Evertsson M; Pediatrics, Department of Clinical Sciences, Faculty of Medicine, Lund University, 22185 Lund, Sweden.; Department of Clinical Sciences Lund, Biomedical Engineering, Lund University, 22363 Lund, Sweden., Jansson T; Department of Clinical Sciences Lund, Biomedical Engineering, Lund University, 22363 Lund, Sweden.; Clinical Engineering Skåne, Digitalisering IT/MT, RegionSkåne, 22185 Lund, Sweden., Stenström P; Pediatrics, Department of Clinical Sciences, Faculty of Medicine, Lund University, 22185 Lund, Sweden.; Department of Pediatric Surgery, Skåne University Hospital Lund, 22185 Lund, Sweden., Cinthio M; Department of Biomedical Engineering, Faculty of Engineering, Lund University, 22363 Lund, Sweden.

Publikováno v: Diagnostics (Basel, Switzerland) [Diagnostics (Basel)] 2023 Aug 25; Vol. 13 (17). Date of Electronic Publication: 2023 Aug 25.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

The critical role of apoptosis in mesenchymal stromal cell therapeutics and implications in homeostasis and normal tissue repair.

Autor: Giacomini C; School of Cardiovascular and Metabolic Medicine & Sciences, King's College London, London, UK. chiara.giacomini@kcl.ac.uk., Granéli C; BioPharmaceuticals R&D Cell Therapy Department, Research and Early Development, Cardiovascular, Renal, and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Hicks R; School of Cardiovascular and Metabolic Medicine & Sciences, King's College London, London, UK.; BioPharmaceuticals R&D Cell Therapy Department, Research and Early Development, Cardiovascular, Renal, and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Dazzi F; School of Cardiovascular and Metabolic Medicine & Sciences, King's College London, London, UK. francesco.dazzi@kcl.ac.uk.; BioPharmaceuticals R&D Cell Therapy Department, Research and Early Development, Cardiovascular, Renal, and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden. francesco.dazzi@kcl.ac.uk.

Publikováno v: Cellular & molecular immunology [Cell Mol Immunol] 2023 Jun; Vol. 20 (6), pp. 570-582. Date of Electronic Publication: 2023 Apr 25.